Style | Citing Format |
---|---|
MLA | Fendereski A, et al.. "Factors Associated With Survival of Patients With Leukemia Using Penalized Splines and Comparing That With the Cox Proportional Hazards Model." Journal of Mazandaran University of Medical Sciences, vol. 33, no. 222, 2023, pp. 44-55. |
APA | Fendereski A, Charati JY, Nodehi SRS, Tahamtan RAM (2023). Factors Associated With Survival of Patients With Leukemia Using Penalized Splines and Comparing That With the Cox Proportional Hazards Model. Journal of Mazandaran University of Medical Sciences, 33(222), 44-55. |
Chicago | Fendereski A, Charati JY, Nodehi SRS, Tahamtan RAM. "Factors Associated With Survival of Patients With Leukemia Using Penalized Splines and Comparing That With the Cox Proportional Hazards Model." Journal of Mazandaran University of Medical Sciences 33, no. 222 (2023): 44-55. |
Harvard | Fendereski A et al. (2023) 'Factors Associated With Survival of Patients With Leukemia Using Penalized Splines and Comparing That With the Cox Proportional Hazards Model', Journal of Mazandaran University of Medical Sciences, 33(222), pp. 44-55. |
Vancouver | Fendereski A, Charati JY, Nodehi SRS, Tahamtan RAM. Factors Associated With Survival of Patients With Leukemia Using Penalized Splines and Comparing That With the Cox Proportional Hazards Model. Journal of Mazandaran University of Medical Sciences. 2023;33(222):44-55. |
BibTex | @article{ author = {Fendereski A and Charati JY and Nodehi SRS and Tahamtan RAM}, title = {Factors Associated With Survival of Patients With Leukemia Using Penalized Splines and Comparing That With the Cox Proportional Hazards Model}, journal = {Journal of Mazandaran University of Medical Sciences}, volume = {33}, number = {222}, pages = {44-55}, year = {2023} } |
RIS | TY - JOUR AU - Fendereski A AU - Charati JY AU - Nodehi SRS AU - Tahamtan RAM TI - Factors Associated With Survival of Patients With Leukemia Using Penalized Splines and Comparing That With the Cox Proportional Hazards Model JO - Journal of Mazandaran University of Medical Sciences VL - 33 IS - 222 SP - 44 EP - 55 PY - 2023 ER - |